JoinTherapeutics participated in the call for proposals of UNI-Impresa 2018 of the University of Padua.

This participation refers to the project entitled “New directions in osteoarthritis therapy: in-vitro study of the effects of some ligand molecules for CD44, CB2 receptors and for galectins-1 and -3”. The proposal was successful and research activities promptly started in Q1-2019.


The call for proposals aims at promoting and developing the transfer of knowledge between Academia and private companies.